Colorectal Cancer

The best of humanity met me at the worst time of my life when I found “my people” after receiving a stage 4 colorectal cancer diagnosis.

Patients with type 2 diabetes have an increased cancer burden and, as a result, a higher mortality rate, highlighting the importance of inflammatory factors like obesity and glucose control.

In 2023, my goal is to continue building my role as a patient advocate and to support other cancer survivors in the fight through the various organizations I am involved with.

Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.

The PRESERVE 1 trial was discontinued due to responses and survival measures favoring placebo versus Cosela when added to a chemoimmunotherapy regimen.

Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead to lower quality of life after treatment.

Many men — my former self included — can be stubborn when it comes to cancer screenings or visiting the doctor. Thankfully I’ve changed my ways, which saved my life.

Patients with refractory metastatic colorectal cancer often don’t have many effective treatment options, although immunotherapy may be a promising potential for patients based on recent study findings.

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

The FDA recently approved a combination treatment for patients with previously treated metastatic colorectal cancer with HER2-positive disease determined by biomarker testing.

I recently met another woman with Lynch syndrome, the same hereditary cancer syndrome that I have, and it made me reflect on the steps I was taking to maintain my health.

The multicenter study is evaluating the safety and efficacy of nanrilkefusp alfa combined with Erbitux.

The FDA approved Tukysa plus Herceptin for previously treated patients with HER2-positive metastatic colorectal cancer.

The COVALENT-102 trial will investigate BMF-219 in patients with non-small cell lung cancer, colorectal and pancreatic cancers.

A test that measures tumor DNA in the blood could be a helpful prognostic factor in patients with colorectal cancer who underwent surgery.

Treatments before surgery for rectal adenocarcinoma, a type of rectal cancer, have increased and correlated with preservative surgeries and improved overall survival in the last 16 years, though improvements may still be needed for disease screening, an expert said.

I’ve heard the phrase, “don’t waste your cancer,” as a way to encourage survivors to tell their stories and donate to nonprofits.

Exercising moderately every week has been linked to improved disease outcomes at any BMI in patients with colorectal cancer.

Pelé died on Dec. 29, 2022, from complications related to his colon cancer.

From the death of a Broadway actor to TV stars completing treatment, here’s what’s happening in the cancer space this week.

Recent research unveiled groups of patients with colorectal cancer who should undergo more frequent scans to detect disease that has spread to the lungs.

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

The Food and Drug Administration granted a priority review for Tukysa plus Herceptin for patients with pretreated, metastatic colon cancer.

Despite my mother and grandmother’s history with the disease, I never thought I would one day receive a colon cancer diagnosis.